Intellia Therapeutics Inc banner

Intellia Therapeutics Inc
NASDAQ:NTLA

Watchlist Manager
Intellia Therapeutics Inc Logo
Intellia Therapeutics Inc
NASDAQ:NTLA
Watchlist
Price: 12.37 USD -6.57% Market Closed
Market Cap: $1.5B

Intrinsic Value

The intrinsic value of one NTLA stock under the Base Case scenario is 11.35 USD. Compared to the current market price of 12.37 USD, Intellia Therapeutics Inc is Overvalued by 8%.

NTLA Intrinsic Value
11.35 USD
Overvaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value $9.08
Get notified when the price drops into your buy zone
Current Price $12.37
Intrinsic Value $11.35
Margin of Safety 20% $9.08
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about NTLA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NTLA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Intellia Therapeutics Inc.

Explain Valuation
Alternatives to NTLA

Wall St
Price Targets

Dividends

Intellia Therapeutics Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

NTLA Insider Trading
Buy and sell transactions by insiders

NTLA News

What is the Intrinsic Value of one NTLA stock?

The intrinsic value of one NTLA stock under the Base Case scenario is 11.35 USD.

Is NTLA stock undervalued or overvalued?

Compared to the current market price of 12.37 USD, Intellia Therapeutics Inc is Overvalued by 8%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett